GABAergic Function in Alzheimer's Disease: Evidence for Dysfunction and Potential as a Therapeutic Target for the Treatment of Behavioural and Psychological Symptoms of Dementia

Psychopharmacology: The third generation of progress

O’Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,020 · see citing works

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Perry, E., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P., & Perry, R. H. (1978) · British medical journal · doi:10.1136/bmj.2.6150.1457 · Cited by 2,043 · see citing works

Psychopharmacology: The Third Generation of Progress.

(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,021 · see citing works

The Biochemical Basis of Neuropharmacology.

(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-575_2 · Cited by 1,882 · see citing works

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736 · see citing works

Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172 · see citing works

Diagnosis and Treatment of Alzheimer Disease and Related Disorders

Small, G. W. (1997) · JAMA · doi:10.1001/jama.1997.03550160083043 · Cited by 984 · see citing works

Molecular and neuronal substrate for the selective attenuation of anxiety

Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946 · see citing works

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944 · see citing works

ALZHEIMER'S DISEASE INTERNATIONAL

Graham, N., & Brodaty, H. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199707)12:7 · Cited by 852 · see citing works

Neurotransmitter-related enzymes in senile dementia of the alzheimer type

Davies, P. (1979) · Brain Research · doi:10.1016/0006-8993(79)90336-6 · Cited by 634 · see citing works

The ‘ABC’ of GABA receptors

Bormann, J. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01413-3 · Cited by 629 · see citing works

GABA receptor mechanisms in the central nervous system

Sivilotti, L. G., & Nistri, A. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90036-z · Cited by 554 · see citing works

The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory

Decker, M. W., & McGaugh, J. L. (1991) · Synapse · doi:10.1002/syn.890070209 · Cited by 524 · see citing works

A POST-MORTEM STUDY OF THE CHOLINERGIC AND GABA SYSTEMS IN SENILE DEMENTIA

Rossor, M. N., Garrett, N., Johnson, A. L., Mountjoy, C. Q., Roth, M., & Iversen, L. L. (1982) · Brain · doi:10.1093/brain/105.2.313 · Cited by 460 · see citing works

The ABC of GABA receptors: a brief review

Chebib, M., & Johnston, G. A. R. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03151.x · Cited by 436 · see citing works

Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia

Tariot, P. N., Erb, R., Podgorski, C. A., Cox, C., Patel, S., Jakimovich, L., & Irvine, C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.54 · Cited by 422 · see citing works

Neurochemical characteristics of early and late onset types of Alzheimer's disease.

Rossor, M. N., Iversen, L. L., Reynolds, G. P., Mountjoy, C. Q., & Roth, M. (1984) · BMJ · doi:10.1136/bmj.288.6422.961 · Cited by 417 · see citing works

Studies of the uptake of3H-GABA and [3H]glycine in slices and homogenates of rat brain and spinal cord by electron microscopic autoradiography

Iversen, L. L., & Bloom, F. E. (1972) · Brain Research · doi:10.1016/0006-8993(72)90621-x · Cited by 369 · see citing works

The Course of Psychopathologic Features in Mild to Moderate Alzheimer Disease

Devanand, D. P. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830150083012 · Cited by 347 · see citing works

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

Reisine, T., Yamamura, H. I., Bird, E. D., Spokes, E. G., & Enna, S. J. (1978) · Brain Research · doi:10.1016/0006-8993(78)90562-0 · Cited by 342 · see citing works

Transmitter deficits in Alzheimer's disease

Hardy, J., Adolfsson, R., Alafuzoff, I. I., Bucht, G., Marcusson, J. O., Nyberg, P., Perdahl, E., Wester, P. O., & Winblad, B. G. (1985) · Neurochemistry International · doi:10.1016/0197-0186(85)90050-6 · Cited by 329 · see citing works

The Biochemical Basis of Neuropharmacology

(1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)89442-5 · Cited by 328 · see citing works

Dementia of the Alzheimer's Type: Changes in Hippocampal L‐[ 3 H]Glutamate Binding

Greenamyre, J. T., Penney, J. B., D’Amato, C. J., & Young, A. B. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb04127.x · Cited by 279 · see citing works

The Cholinergic Hypothesis of Neuropsychiatric Symptoms in Alzheimer's Disease

Cummings, J. L., & Back, C. (1998) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199821001-00009 · Cited by 274 · see citing works

The Glutamatergic System and Alzheimer???s Disease

Butterfield, D. A., & Pocernich, C. B. (2003) · CNS Drugs · doi:10.2165/00023210-200317090-00004 · Cited by 267 · see citing works

Enzyme Activities in Relation to pH and Lactate in Postmortem Brain in Alzheimer‐Type and Other <i>Dementias</i>

Yates, C. M., Butterworth, J., Tennant, M. C., & Gordon, A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04948.x · Cited by 263 · see citing works

Neuropsychiatric aspects of Alzheimer's disease

Cummings, J. L., & Kaufer, D. (1996) · Neurology · doi:10.1212/wnl.47.4.876 · Cited by 252 · see citing works

Amino Acid Transmitters

Curtis, D. R., & Johnston, G. A. R. (1970) · Springer eBooks · doi:10.1007/978-1-4615-7163-6_5 · Cited by 232 · see citing works

Placebo-Controlled Study of Divalproex Sodium for Agitation in Dementia

Porsteinsson, A. P., Tariot, P. N., Erb, R., Cox, C., Smith, E., Jakimovich, L. J., Noviasky, J. A., Kowalski, N., Holt, C. J., & Irvine, C. (2001) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200102000-00009 · Cited by 206 · see citing works

GABA and hippocampal inhibition

Curtis, D. R., Felix, D., & McLellan, H. (1970) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1970.tb10663.x · Cited by 199 · see citing works

Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo A Double-blind, Randomized Study in Acutely Agitated Patients with Dementia

Meehan, K. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00365-7 · Cited by 198 · see citing works

Alzheimer's disease: Changes in hippocampal N-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study

Jansen, K. L. R., Faull, R. L. M., Dragunow, M., & Synek, B. J. L. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90246-z · Cited by 197 · see citing works

A Pilot Randomized Trial of Carbamazepine for Behavioral Symptoms in Treatment-Resistant Outpatients with Alzheimer Disease

Olin, J. T., Fox, L. S., Pawluczyk, S., Taggart, N. A., & Schneider, L. S. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00008 · Cited by 163 · see citing works

A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease

Reinikainen, K. J., Paljärvi, L., Huuskonen, M., Soininen, H. S., Laakso, M., & Riekkinen, P. J. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90179-7 · Cited by 154 · see citing works

Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia

Lanctôt, K. L., Herrmann, N., & Mazzotta, P. (2001) · Journal of Neuropsychiatry · doi:10.1176/jnp.13.1.5 · Cited by 153 · see citing works

Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease

Jiménez‐Jiménez, F. J., Molina, J. A., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González‐Muñoz, M. J., de Bustos, F., Martínez‐Salio, A., Pareja, M. O., Zurdo, M., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050073 · Cited by 151 · see citing works

Benzodiazepines as antidepressants: Does GABA play a role in depression?

Petty, F., Trivedi, M. H., Fulton, M., & Rush, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00049-7 · Cited by 143 · see citing works

A postmortem study of amino acid neurotransmitters in Alzheimer's disease

Ellison, D. W., Beal, M. F., Mazurek, M. F., Bird, E. D., & Martin, J. B. (1986) · Annals of Neurology · doi:10.1002/ana.410200510 · Cited by 139 · see citing works

Levels of -Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders

Manyam, N. V. B., Katz, L., Hare, T. A., Gerber, J. C., & Grossman, M. H. (1980) · Archives of Neurology · doi:10.1001/archneur.1980.00500550054006 · Cited by 135 · see citing works

GAMMA-AMINOBUTYRIC ACID CONCENTRATION IN BRAIN TISSUE AT TWO STAGES OF ALZHEIMER'S DISEASE

Lowe, S. L., Francis, P. T., PROCTER, A. W., Palmer, A. M., DAVISON, A. N., & Bowen, D. M. (1988) · Brain · doi:10.1093/brain/111.4.785 · Cited by 132 · see citing works

Cerebrospinal Fluid -Aminobutyric Acid Variations in Neurological Disorders

Enna, S. J., Stern, L. Z., Wastek, G. J., & Yamamura, H. I. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500230053008 · Cited by 121 · see citing works

Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease

Perry, T. L., Yong, V. W., Bergeron, C., Hansen, S., & Jones, K. L. (1987) · Annals of Neurology · doi:10.1002/ana.410210403 · Cited by 121 · see citing works

Carbamazepine Treatment of Agitation in Nursing Home Patients with Dementia: A Preliminary Study

Tariot, P. N., Erb, R., Leibovici, A., Podgorski, C. A., Cox, C., Asnis, J., Kolassa, J. E., & Irvine, C. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06982.x · Cited by 120 · see citing works

Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial

Tariot, P. N., Schneider, L. S. S., Mintzer, J. E., Cutler, A. J., Cunningham, M. R., Thomas, J. W., & Sommerville, K. W. (2001) · Current Therapeutic Research · doi:10.1016/s0011-393x(01)80042-4 · Cited by 118 · see citing works

Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients

Coccaro, E. F., Kramer, E., Zemishlany, Z., Thorne, A., Rice, C. M., Giordani, B., Duvvi, K., Patel, B. M., Torres, J., & Nora, R. M. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.12.1640 · Cited by 115 · see citing works

Sodium valproate in the treatment of aggressive behavior in patients with dementia—a randomized placebo controlled clinical trial

Sival, R. C., Haffmans, P. M. J., Jansen, P. A. F., Duursma, S. A., & Eikelenboom, P. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.653 · Cited by 115 · see citing works

Valproate in the treatment of behavioral agitation in elderly patients with dementia

Lott, A. D., McElroy, S. L., & Keys, M. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.3.314 · Cited by 114 · see citing works

A disorder of cortical GABAergic innervation in Alzheimer's disease

Hardy, J., Cowburn, R. F., BARTON, A. J. L., Reynolds, G. P., Dodd, P. R., Wester, P. O., O’Carroll, A., Lofdahl, E., & Winblad, B. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90016-4 · Cited by 114 · see citing works

The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia

Cross, A. J., Crow, T. J., Ferrier, I. N., & Johnson, J. A. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90019-9 · Cited by 112 · see citing works

Insights into the structure and function of GABA-benzodiazepine receptors: ion channels and psychiatry

Zorumski, C. F., & Isenberg, K. E. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.162 · Cited by 111 · see citing works

Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type

Sasaki, H., Muramoto, O., Kanazawa, I., Arai, H., Kosaka, K., & Iizuka, R. (1986) · Annals of Neurology · doi:10.1002/ana.410190307 · Cited by 110 · see citing works

Sodium Valproate in the Treatment of Behavioral Disturbance in Dementia

Mellow, A. M., Solano-Lopez, C., & Davis, S. (1993) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879300600404 · Cited by 110 · see citing works

Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology

Seidl, R., Cairns, N. J., Singewald, N., Kaehler, S. T., & Lübec, G. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000346 · Cited by 109 · see citing works

Decreased CSF Concentrations of Homovanillic Acid and γ-Aminobutyric Acid in Alzheimer's Disease

Bareggi, S. R. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510230035010 · Cited by 107 · see citing works

Benzodiazepines May Have Protective Effects Against Alzheimer Disease

Fastbom, J., Forsell, Y., & Winblad, B. G. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199803000-00002 · Cited by 102 · see citing works

Cortical GABA B and GABA A receptors in Alzheimer's disease

Chu, D. C. M., Penney, J. B., & Young, A. B. (1987) · Neurology · doi:10.1212/wnl.37.9.1454 · Cited by 100 · see citing works

Neurochemical substrates of rigidity and chorea in Huntington's disease

Storey, E., & Beal, M. F. (1993) · Brain · doi:10.1093/brain/116.5.1201 · Cited by 99 · see citing works

Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease

Jiménez‐Jiménez, F. J., Molina, J. A., Gómez, P. A., Vargas, C., de Bustos, F., Benito‐León, J., Tallón-Barranco, A., Pareja, M. O., Gasalla, T., & Arenas, J. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050056 · Cited by 98 · see citing works

[3H]R05-4864 and [3H]flunitrazepam binding in kainate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type

Owen, F., Poulter, M., Waddington, J. L., Mashal, R. D., & Crow, T. J. (1983) · Brain Research · doi:10.1016/0006-8993(83)90276-7 · Cited by 95 · see citing works

Intralaminar Neurochemical Distributions in Human Midtemporal Cortex: Comparison Between Alzheimer's Disease and the Normal

Perry, E. K., Atack, J. R., Perry, R. H., Hardy, J., Dodd, P. R., Edwardson, J. A., Blessed, G., Tomlinson, B. E., & FAIRBAIRN, A. F. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb02801.x · Cited by 92 · see citing works

Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.

Gleason, R. P., & Ls, S. (1990) · PubMed · Cited by 92 · see citing works

Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex

Drew, A. E., Derbez, A. E., & Werling, L. L. (2000) · Synapse · doi:10.1002/1098-2396(200010)38:1 · Cited by 89 · see citing works

GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses

Keverne, E. B. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00025-8 · Cited by 86 · see citing works

New Insights Into The Mechanism of Action of Hypnotics

Doble, A. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901304s03 · Cited by 77 · see citing works

Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease

Smith, C., Bowen, D. M., Sims, N. R., Neary, D., & DAVISON, A. N. (1983) · Brain Research · doi:10.1016/0006-8993(83)91131-9 · Cited by 77 · see citing works

Positron Emission Tomography Measures of Benzodiazepine Binding in Alzheimer's Disease

Meyer, M., Koeppe, R. A., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540270110027 · Cited by 75 · see citing works

Hippocampal Free Amino Acids in Alzheimer's Disease

Tarbit, I., Perry, E. K., Perry, R. H., Blessed, G., & Tomlinson, B. E. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb07883.x · Cited by 75 · see citing works

erratum: Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J., Martin, J. R., Bluethmann, H., & Möhler, H. (2000) · Nature · doi:10.1038/35007116 · Cited by 71 · see citing works

Valproic Acid Treatment of Agitation in Dementia

Herrmann, N. (1998) · The Canadian Journal of Psychiatry · doi:10.1177/070674379804300108 · Cited by 70 · see citing works

An Open Trial of Valproate for Agitation in Geriatric Neuropsychiatric Disorders

Porsteinsson, A. P., Tariot, P. N., Erb, R., & Gaile, S. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700540-00010 · Cited by 70 · see citing works

A preliminary study of free amino acids in the postmorten temporal cortex from Alzheimer-type dementia patients

Arai, H., Kobayashi, K., Ichimiya, Y., Kosaka, K., & Iizuka, R. (1984) · Neurobiology of Aging · doi:10.1016/0197-4580(84)90009-5 · Cited by 70 · see citing works

Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer's disease

Chu, D. C. M., Penney, J. B., & Young, A. B. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90264-3 · Cited by 69 · see citing works

Density and pharmacology of α5 subunit-containing GABAA receptors are preserved in hippocampus of Alzheimer’s disease patients

Howell, O. W., Atack, J. R., Dewar, D., McKernan, R. M., & Sur, C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00163-9 · Cited by 67 · see citing works

Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease

Sherif, F. M., Gottfries, C. G., Alafuzoff, I. I., & Oreland, L. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260906 · Cited by 67 · see citing works

-Aminobutyric Acid and Homovanillic Acid Concentration in the CSF of Patients With Senile Dementia of Alzheimer's Type

Zimmer, R., Teelken, A. W., Trieling, W. B., Weber, W., Weihmayr, T., & Lauter, H. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04210080010005 · Cited by 67 · see citing works

Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms

PROCTER, A. W., Francis, P. T., Stratmann, G. C., & Bowen, D. M. (1992) · Neurochemical Research · doi:10.1007/bf00993268 · Cited by 65 · see citing works

Drugs and stimulus-bound attack

Panksepp, J. (1971) · Physiology & Behavior · doi:10.1016/0031-9384(71)90162-4 · Cited by 64 · see citing works

An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains

Mohanakrishnan, P., Fowler, A. H., Vonsattel, J. P., Husain, M. M., Jolles, P. R., Liem, P. H., & Komoroski, R. A. (1995) · Experimental Brain Research · doi:10.1007/bf00230654 · Cited by 62 · see citing works

Effectiveness of Gabapentin for the Treatment of Behavioral Disorders in Dementia

Herrmann, N., Lanctôt, K. L., & Myszak, M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00015 · Cited by 61 · see citing works

Occurrence of Thrombocytopenia in Psychiatric Patients Taking Valproate

Trannel, T. J., Ahmed, I., & Goebert, D. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.128 · Cited by 61 · see citing works

NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex

Carlson, M. D., Penney, J. B., & Young, A. B. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90120-z · Cited by 58 · see citing works

Changes in benzodiazepine receptors in alzheimer‐type dementia

Shimohama, S., Taniguchi, T., Fujiwara, M., & Kameyama, M. (1988) · Annals of Neurology · doi:10.1002/ana.410230419 · Cited by 58 · see citing works

Withdrawal From Controlled Carbamazepine Therapy Followed by Further Carbamazepine Treatment in Patients With Dementia

Tariot, P. N., Jakimovich, L. J., Erb, R., Cox, C., Lanning, B. D., Irvine, C., & Podgorski, C. A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1007 · Cited by 57 · see citing works

Treatment of Dementia With Behavioral Disturbance Using Divalproex or a Combination of Divalproex and a Neuroleptic

Narayan, M., & Nelson, J. C. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0804 · Cited by 56 · see citing works

Increased .GAMMA.-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease.

AOYAGI, T., Wada, T., Nagai, M., KOJIMA, F., HARADA, S., TAKEUCHI, T., Takahashi, H., HIROKAWA, K., & TSUMITA, T. (1990) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.38.1748 · Cited by 56 · see citing works

Comparison of Thioridazine and Diazepam in the Control of Nonpsychotic Symptoms Associated with Senility: Double‐Blind Study

KIRVEN, L. E., & MONTERO, E. F. (1973) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1973.tb01661.x · Cited by 55 · see citing works

The Effect of Diazepam Sedation on Cerebral Glucose Metabolism in Alzheimer's Disease as Measured Using Positron Emission Tomography

Foster, N. L., VanDerSpek, A. F. L., Aldrich, M. S., Berent, S., Hichwa, R. D., Sackellares, J. C., Gilman, S., & Agranoff, B. W. (1987) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1987.84 · Cited by 55 · see citing works

Recent advances in GABA research

Kardos, J. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00036-4 · Cited by 55 · see citing works

Activation of Muscarinic Receptors Inhibits औ-Amyloid Peptide-induced Signaling in Cortical Slices

Gu, Z., Zhong, P., & Yan, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209892200 · Cited by 54 · see citing works

Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes.

Horne, M. K., & Lindley, S. E. (1995) · PubMed · Cited by 53 · see citing works

Treatment of Dementia-Associated Agitation With Gabapentin

Roane, D. M., Feinberg, T. E., Meckler, L., Miner, C. R., Scicutella, A., & Rosenthal, R. N. (2000) · Journal of Neuropsychiatry · doi:10.1176/jnp.12.1.40 · Cited by 53 · see citing works

Preserved benzodiazepine receptors in Alzheimer’s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF

Ohyama, M., Senda, M., Ishiwata, K., Kitamura, S., Mishina, M., Ishii, K., Toyama, H., Oda, K., & Katayama, Y. (1999) · Annals of Nuclear Medicine · doi:10.1007/bf03164869 · Cited by 53 · see citing works

Alprazolam as an Alternative to Low‐Dose Haloperidol in Older, Cognitively Impaired Nursing Facility Patients

Christensen, D. B., & Benfield, W. R. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb01081.x · Cited by 52 · see citing works

Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics.

Lemke, M. R. (1995) · PubMed · Cited by 51 · see citing works

Alleviating Agitation, Apprehension, and Related Symptoms in Geriatric Patients

COVINGTON, J. S. (1975) · Southern Medical Journal · doi:10.1097/00007611-197506000-00015 · Cited by 50 · see citing works

A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease

Griffiths, P. D., Perry, R. H., & Crossman, A. R. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90358-1 · Cited by 49 · see citing works

Carbamazepine Treatment of Agitation Associated with Dementia

Leibovici, A., & Tariot, P. N. (1988) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198878800100208 · Cited by 49 · see citing works

Behavioural responses of bicucculline methiodide injections into the ventral hypothalamus of freely moving, socially interacting rats

Roeling, T. A. P., Kruk, M. R., Schuurmans, R., & Veening, J. G. (1993) · Brain Research · doi:10.1016/0006-8993(93)91122-9 · Cited by 48 · see citing works

Laminar Alterations in γ‐Aminobutyric AcidA, Muscarinic, and β Adrenoceptors and Neuron Degeneration in Cingulate Cortex in Alzheimer's Disease

Vogt, B. A., Crino, P. B., & Volicer, L. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02126.x · Cited by 47 · see citing works

Alterations in the brain GABAA/benzodiazepine receptor-chloride ionophore complex in a genetic model of paroxysmal dystonia: A quantitative autoradiographic analysis

Nóbrega, J. N., Richter, A., Burnham, W. M., & Löscher, W. N. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00334-2 · Cited by 45 · see citing works

A Preliminary Study of Carbamazepine in the Treatment of Assaultive Patients With Dementia

Patterson, J. F. (1988) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198878800100105 · Cited by 45 · see citing works

Offense produced by chemical stimulation of the anterior hypothalamus of the rat

Adams, D. B., Boudreau, W., Cowan, C. W., Kokonowski, C., Oberteuffer, K., & Yohay, K. H. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90369-q · Cited by 44 · see citing works

Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and alzheimer patients: a comparison

Yew, D. T. W., Li, W., Webb, S., Lai, H. W. L., & Zhang, L. (1999) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00017-5 · Cited by 43 · see citing works

THE EFFECTS OF SODIUM VALPROATE ON DISTURBED BEHAVIOR IN DEMENTIA

Sival, R. C., Haffmans, P. M. J., Gent, P., Jf, V. N., & Jansen, P. A. F. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06571.x · Cited by 43 · see citing works

Co-Use of Donepezil and Hypnotics Among Alzheimer's Disease Patients Living in the Community

Stahl, S. M., Markowitz, J. S., Gutterman, E. M., & Papadopoulos, G. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0418 · Cited by 43 · see citing works

GABA-Agonist Therapy for Alzheimerʼs Disease

Mohr, E., Bruno, G., Foster, N. L., Gillespie, M., Cox, C., Hare, T. A., Tamminga, C. A., Fedio, P., & Chase, T. N. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198606000-00004 · Cited by 43 · see citing works

A Retrospective Chart Review of Gabapentin for the Treatment of Aggressive and Agitated Behavior in Patients With Dementias

Hawkins, J. W., Tinklenberg, J. R., Sheikh, J. I., Peyser, C. E., & Yesavage, J. A. (2000) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200008000-00007 · Cited by 41 · see citing works

Carbamazepine for assaultive patients with organic brain disease

Patterson, J. F. (1987) · Psychosomatics · doi:10.1016/s0033-3182(87)72456-6 · Cited by 40 · see citing works

Divalproex: a Possible Treatment Alternative for Demented, Elderly Aggressive Patients

Haas, S., Vincent, K., Holt, J., & Lippmann, S. (1997) · Annals of Clinical Psychiatry · doi:10.1023/a:1026273806909 · Cited by 38 · see citing works

Carbamazepine in Dementia

ESSA, M. (1986) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198608000-00007 · Cited by 37 · see citing works

Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls

Sunderland, T., Weingartner, H., Cohen, R. M., Tariot, P. N., NEWHOUSE, P. A., Thompson, K., LAWLOR, B. A., & Mueller, E. A. (1989) · Psychopharmacology · doi:10.1007/bf00634466 · Cited by 37 · see citing works

Zolpidem for Dementia-Related Insomnia and Nighttime Wandering

Shelton, P. S., & Hocking, L. B. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100309 · Cited by 35 · see citing works

A selective reduction of excitatory amino acids in cerebrospinal fluid of patients with Alzheimer type dementia compared with vascular dementia of the Binswanger type

Tohgi, H., Abe, T., Takahashi, S., & Kimura, M. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90321-w · Cited by 33 · see citing works

Laboratory examinations correlated with severity of dementia.

Oishi, M., Mochizuki, Y., Yoshihashi, H., Takasu, T., & Nakano, E. (1996) · PubMed · Cited by 32 · see citing works

Agitation in the Demented Elderly

Ancill, R. J., Carlyle, W., LIANG, R. A., & Holliday, S. G. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100630-00002 · Cited by 31 · see citing works

GABA transporters (GAT-1) in Alzheimer's disease

Nägga, K., Bogdanović, N., & Marcusson, J. O. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050230 · Cited by 31 · see citing works

Carbamazepine for aggressive agitation in demented patients during nursing care

Marin, D. B., & GREENWALD, B. S. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.805 · Cited by 31 · see citing works

Valproic Acid for Physically Aggressive Behavior in Geriatric Patients

Sandborn, W. D., Bendfeldt, F., & Hamdy, R. C. (1995) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199522330-00007 · Cited by 30 · see citing works

Psychotropic Drug Utilization in Long-Term-Care Facilities for the Elderly in Ontario, Canada

Conn, D. K., Ferguson, I., Mandelman, K., & Ward, C. (1999) · International Psychogeriatrics · doi:10.1017/s1041610299005797 · Cited by 29 · see citing works

Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease.

Fukuchi, K., Hashikawa, K., Seike, Y., Moriwaki, H., Oku, N., Ishida, M., Fujita, M., Uehara, T., Tanabe, H., Kusuoka, H., et al. (1997) · PubMed · Cited by 29 · see citing works

EVALUATION OF OXAZEPAM AND PLACEBO IN EMOTIONALLY DISTURBED AGED PATIENTS.

Jf, S. (1965) · PubMed · Cited by 29 · see citing works

Neurochemical Bases of Aggressive Behavior

Eichelman, B. S. (1987) · Psychiatric Annals · doi:10.3928/0048-5713-19870601-07 · Cited by 28 · see citing works

GABA-Transaminase in brain and blood platelets: Basic and clinical aspects

Sherif, F. M. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90089-2 · Cited by 27 · see citing works

Divalproex: a Possible Treatment Alternative for Demented, Elderly Aggressive Patients

Haas, S., Vincent, K., Holt, J., et al. (1997) · Annals of Clinical Psychiatry · doi:10.3109/10401239709147789 · Cited by 27 · see citing works

Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.

Kuroda, H. (1983) · PubMed · doi:10.18926/amo/32437 · Cited by 26 · see citing works

Valproate-Associated Dysmyelopoiesis in Elderly Patients

So, C. C., & Wong, K.-F. (2002) · American Journal of Clinical Pathology · doi:10.1309/4tef-lvgx-weq9-r8w8 · Cited by 24 · see citing works

Management of behavior in the institutionalized aged.

Cr, B. (1965) · PubMed · Cited by 23 · see citing works

GABA and brain abnormalities in schizophrenia

van Kammen, D. (1998) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(98)00006-7 · Cited by 21 · see citing works

Case Report of Carbamazepine Treatment of Organic Brain Syndrome with Psychotic Features

ANTON, R. F., Waid, L. R., Fossey, M. D., & AuBuchon, P. G. (1986) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198608000-00006 · Cited by 19 · see citing works

Clonazepam Treatment of Multi-infarct Dementia

Smeraski, P. J. (1988) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198878800100108 · Cited by 19 · see citing works

Effects of psychotherapeutic drugs on hypothalamic-induced hissing in cats

Funderburk, W. H., Foxwell, M. H., & Hakala, M. W. (1970) · Neuropharmacology · doi:10.1016/0028-3908(70)90042-0 · Cited by 18 · see citing works

Clonazepam treatment of organic brain syndromes in three elderly patients.

Jp, F., & Alvarez, W. A. (1986) · PubMed · Cited by 18 · see citing works

Striatal Expression of Glutamic Acid Decarboxylase Gene in Alzheimer's Disease

Boissière‐Michot, F., Faucheux, B. A., Duyckaerts, C. J., Hauw, J., Agid, Y., & Hirsch, É. C. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020767.x · Cited by 16 · see citing works

CSF GABA in caregiver spouses of Alzheimer patients

Pomara, N., Deptula, D., Galloway, M. P., LeWitt, P. A., & Stanley, M. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.787 · Cited by 16 · see citing works

Cerebrospinal fluid and plasma gamma-aminobutyric acid in Alzheimer's disease

Weiner, M., Speciale, S. G., Risser, R. C., Kramer, G. L., & Petty, F. (1996) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00305-8 · Cited by 15 · see citing works

A Single-Case-Study Method for Treating Resistiveness in patients with Alzheimer's Disease

Herz, L. R., Volicer, L., Ross, V. H., & Rheaume, Y. (1992) · Psychiatric Services · doi:10.1176/ps.43.7.720 · Cited by 14 · see citing works

Neurotransmitter receptor imaging in Alzheimer's disease.

Sedvall, G., Nybäck, H., Farde, L., & Persson, A. (1987) · PubMed · Cited by 14 · see citing works

Pharmacology of recombinant human GABAA receptor subtypes measured using a novel pH-based high-throughput functional efficacy assay

Simpson, P. B., Woollacott, A. J., Pillai, G. V., Maubach, K. A., Hadingham, K. L., Martin, K., Choudhury, H., & Seabrook, G. R. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(00)00219-3 · Cited by 12 · see citing works

Cerebellar GABAA receptors and anxiolytic action of diazepam

Vekovischeva, O. Y., Haapalinna, A., Sarviharju, M., Honkanen, A., & Korpi, E. R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01691-1 · Cited by 12 · see citing works

Glutamate and GABA levels in CSF from patients affected by dementia and olivo-ponto-cerebellar atrophy

Tosca, P., Canevari, L., Paolo, E. D., Ferrari, R., Verzé, S., Zerbi, F., & Dagani, F. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb06042.x · Cited by 11 · see citing works

Clonazepam for Agitated Patients with Alzheimer's Disease

Ginsburg, M. L. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600329 · Cited by 9 · see citing works

Effects of a choline acetyltransferase inhibitor on self-stimulatory behavior in the rat.

Jb, M., & Me, G. (1970) · PubMed · Cited by 5 · see citing works

Brain aminobutyrate aminotransferase activity in Alzheimer's disease.

Sherif, F. M., Ss, A., & Eriksson, L. G. (1995) · PubMed · Cited by 4 · see citing works

Lorazepam treatment of resistive aggression in dementia

Fritz, J., & Stewart, J. T. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.9.1250a · Cited by 4 · see citing works

Senile Dementia and Presenile Dementia

Nakamura, S. (1990) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.161.supplement_49 · Cited by 2 · see citing works

[Anticonvulsants in agitation and behavior disorders in demented subjects. Report of 8 cases].

Fahs, H., Potiron, G., Senon, J., & Perivier, E. (1999) · PubMed · Cited by 2 · see citing works

The Gut Microbiota and Alzheimer’s Disease

Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852 · see citing works

Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons

Rajmohan, R., & Reddy, P. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160612 · Cited by 695 · see citing works

Alzheimer’s disease and gut microbiota

Hu, X., Wang, T., & Jin, F. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5083-9 · Cited by 371 · see citing works

The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology

Doifode, T., Giridharan, V. V., Generoso, J. S., Bhatti, G., Collodel, A., Schulz, P. E., Forlenza, O. V., & Barichello, T. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105314 · Cited by 347 · see citing works

Loss of functional GABA A receptors in the Alzheimer diseased brain

Limón, A., Reyes‐Ruiz, J. M., & Miledi, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204606109 · Cited by 264 · see citing works

Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle

Andersen, J. V., Schousboe, A., & Verkhratsky, A. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102331 · Cited by 259 · see citing works

Alzheimer's-Type Amyloidosis in Transgenic Mice Impairs Survival of Newborn Neurons Derived from Adult Hippocampal Neurogenesis

Verret, L., Jankowsky, J. L., Xu, G. M., Borchelt, D., & Rampon, C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5564-06.2007 · Cited by 226 · see citing works

Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease

Govindpani, K., Calvo-Flores Guzmán, B., Vinnakota, C., Waldvogel, H., Faull, R., & Kwakowsky, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081813 · Cited by 208 · see citing works

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease

Najm, R., Jones, E. A., & Huang, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0324-6 · Cited by 183 · see citing works

Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease

Czapski, G. A., & Strosznajder, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111677 · Cited by 194 · see citing works

GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease

Jiménez-Baladó, J., & Eich, T. S. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.01.005 · Cited by 185 · see citing works

Risk of Dementia in Patients with Insomnia and Long-term Use of Hypnotics: A Population-based Retrospective Cohort Study

Chen, P.-L., Lee, W., Sun, W., Oyang, Y., & Fuh, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049113 · Cited by 177 · see citing works

Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease

Paula‐Lima, A. C., Brito‐Moreira, J., & Ferreira, S. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12304 · Cited by 170 · see citing works

The GABAergic system as a therapeutic target for Alzheimer's disease

Guzmán, B. C., Vinnakota, C., Govindpani, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14345 · Cited by 170 · see citing works

Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing

Marcade, M., Bourdin, J., Loiseau, N., Peillon, H., Rayer, A., Drouin, D., Schweighoffer, F., & Désiré, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05396.x · Cited by 155 · see citing works

The amyloid pathology progresses in a neurotransmitter-specific manner

Bell, K. F. S., Ducatenzeiler, A., Ribeiro‐da‐Silva, A., Duff, K., Bennett, D. A., & Cuello, A. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.034 · Cited by 134 · see citing works

Serotonergic Function and Treatment of Behavioral and Psychological Symptoms of Frontotemporal Dementia

Herrmann, N., Black, S. E., Chow, T. W., Cappell, J., Tang‐Wai, D. F., & Lanctôt, K. L. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31823033f3 · Cited by 131 · see citing works

Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease

Takahashi, H., Brasnjevic, I., Rutten, B. P. F., Van Der Kolk, N., Perl, D. P., Bouras, C., Steinbusch, H. W. M., Schmitz, C., Hof, P. R., & Dickstein, D. L. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0242-4 · Cited by 124 · see citing works

Amyloid- Impairs Synaptic Inhibition via GABAA Receptor Endocytosis

Ulrich, D. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0950-15.2015 · Cited by 120 · see citing works

27-Plex Tandem Mass Tag Mass Spectrometry for Profiling Brain Proteome in Alzheimer’s Disease

Wang, Z., Yu, K., Tan, H., Wu, Z., Cho, J.-H., Han, X., Sun, H., Beach, T. G., & Peng, J. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00655 · Cited by 113 · see citing works

Altered synaptic function in Alzheimer's disease

Bell, K. F. S., & Cuello, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.045 · Cited by 112 · see citing works

Decreased γ-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease

Bai, X., Edden, R. A. E., Gao, F., Wang, G., Wu, L., Zhao, B., Wang, M., Chan, Q., Chen, W., & Barker, P. B. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24665 · Cited by 108 · see citing works

GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease

Nava-Mesa, M. O., Jiménez‐Díaz, L., Yajeya, J., & Navarro‐López, J. D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00167 · Cited by 105 · see citing works

A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease

Herrmann, N., Lanctôt, K. L., Rothenburg, L. S., & Eryavec, G. M. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000097757 · Cited by 106 · see citing works

Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape

Salminen, A., Haapasalo, A., Kauppinen, A., Kaarniranta, K., Soininen, H. S., & Hiltunen, M. O. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.001 · Cited by 105 · see citing works

Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer’s disease

Cui, B., Su, D., Li, W., She, X., Zhang, M., Wang, R., & Zhai, Q. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1223-4 · Cited by 103 · see citing works

Neurochemical basis for symptomatic treatment of Alzheimer's disease

Francis, P. T., Ramírez, M. J., & Lai, M. K. P. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.010 · Cited by 104 · see citing works

Difficult Behaviors in Long-term Care Patients With Dementia

Buhr, G. T., & White, H. K. (2007) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2006.12.012 · Cited by 97 · see citing works

Human Gut Microbiota in Health and Alzheimer’s Disease

Szablewski, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170908 · Cited by 92 · see citing works

Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis

Mimura, Y., Nishida, H., Nakajima, S., Tsugawa, S., Morita, S., Yoshida, K., Tarumi, R., Ogyu, K., Wada, M., Kurose, S., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.003 · Cited by 85 · see citing works

40-Hz steady state response in Alzheimer's disease and mild cognitive impairment

van Deursen, J. A., Vuurman, E. F. P. M., van Kranen-Mastenbroek, V. H. J. M., Verhey, F. R. J., & Riedel, W. J. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.002 · Cited by 82 · see citing works

Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype

Riese, F., Gietl, A. F., Zoelch, N., Henning, A., Tuura, R., Kälin, A. M., Leh, S. E., Buck, A., Warnock, G., Edden, R. A. E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.030 · Cited by 81 · see citing works

Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPS cells

Fujiwara, N., Shimizu, J., Takai, K., Arimitsu, N. N., Saito, A., Kono, T., Umehara, T., Ueda, Y., Wakisaka, S., Tomoko, S., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.043 · Cited by 82 · see citing works

An update on the stereoselective synthesis of γ-amino acids

Ordóñez, M., Cativiela, C., & Romero‐Estudillo, I. (2016) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2016.08.011 · Cited by 79 · see citing works

APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease

Hou, M., Xu, G., Ran, M., Luo, W., & Wang, H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.619051 · Cited by 79 · see citing works

Gut Microbiota in Neurological Disorders

Grochowska, M., Laskus, T., & Radkowski, M. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00561-6 · Cited by 73 · see citing works

Pharmacologic Management of Neuropsychiatric Symptoms of Alzheimer Disease

Herrmann, N., & Lanctôt, K. L. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705201004 · Cited by 71 · see citing works

Non human primate models for Alzheimer’s disease-related research and drug discovery

Dam, D. V., & Deyn, P. P. D. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1271320 · Cited by 68 · see citing works

GAD65, GAD67, and GABAT Immunostaining in Human Brain and Apparent GAD65 Loss in Alzheimer's Disease

Schwab, C., Yu, S. Y., Wong, W., McGeer, E. G., & McGeer, P. L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121330 · Cited by 68 · see citing works

Treatment of Alzheimer's disease: From pharmacology to a better understanding of disease pathophysiology

Silvestrelli, G., Lanari, A., Parnetti, L., Tomassoni, D., & Amenta, F. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.018 · Cited by 69 · see citing works

The aspirin metabolite salicylate enhances neuronal excitation in rat hippocampal CA1 area through reducing GABAergic inhibition

Gong, N., Zhang, M., Zhang, X.-B., Chen, L., Sun, G.-C., & Xu, T. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.017 · Cited by 66 · see citing works

Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease

Samakashvili, S., Ibáñez, C., Simó, C., Gil-Bea, F. J., Winblad, B. G., Cedazo-Mı́nguez, Á., & Cifuentes, A. (2011) · Electrophoresis · doi:10.1002/elps.201100139 · Cited by 69 · see citing works

Dihydromyricetin Ameliorates Behavioral Deficits and Reverses Neuropathology of Transgenic Mouse Models of Alzheimer’s Disease

Liang, J., Lindemeyer, A. K., Shen, Y., López-Valdés, H. E., Martínez‐Coria, H., Shao, X. M., & Olsen, R. W. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1304-4 · Cited by 66 · see citing works

Interplay of good bacteria and central nervous system: cognitive aspects and mechanistic considerations

Salami, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.613120 · Cited by 67 · see citing works

Gut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model

Sun, B., Li, W., Wang, J., Xu, Y., Sun, H., Tian, D., Wang, Y., & Yao, X. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181220 · Cited by 66 · see citing works

Clinical practice guidelines for severe Alzheimer's disease

Herrmann, N., Gauthier, S. G., & Lysy, P. G. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.07.007 · Cited by 65 · see citing works

Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers

Manyevitch, R., Protas, M., Scarpiello, S., Deliso, M., Bass, B., Nanajian, A., Chang, M., Thompson, S., Khoury, N. C., Gonnella, R., et al. (2018) · Current Alzheimer Research · doi:10.2174/1567205014666170921122458 · Cited by 65 · see citing works

Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease

Liu, Y., Liu, Z., Wei, M., Hu, M., Yue, K., Bi, R., Zhai, S., Pi, Z., Song, F., & Liu, Z. (2018) · Food & Function · doi:10.1039/c8fo02067a · Cited by 64 · see citing works

Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease

Liu, C. S., Chau, S. A., Ruthirakuhan, M. T., Lanctôt, K. L., & Herrmann, N. (2015) · CNS Drugs · doi:10.1007/s40263-015-0270-y · Cited by 63 · see citing works

Control of N‐Heterocyclic Carbene Catalyzed Reactions of Enals: Asymmetric Synthesis of Oxindole‐γ‐Amino Acid Derivatives

Chen, X., Xiong, J., Liu, Q., Li, S., Sheng, H., von Eßen, C., Rissanen, K. T., & Enders, D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201708994 · Cited by 62 · see citing works

Role of Sleep Disturbance in the Trajectory of Alzheimer’s Disease

Kang, D. W., Lee, C. U., & Lim, H. K. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.2.89 · Cited by 60 · see citing works

Behavioral correlates of GABAergic disruption in Alzheimer's disease

Lanctôt, K. L., Herrmann, N., Rothenburg, L. S., & Eryavec, G. M. (2006) · International Psychogeriatrics · doi:10.1017/s1041610206003899 · Cited by 59 · see citing works

GABA‐containing compound gammapyrone protects against brain impairments in Alzheimer’s disease model male rats and prevents mitochondrial dysfunction in cell culture

Piļipenko, V., Narbute, K., Amara, I., Salinaro, A. T., Scuto, M. C., Pupure, J., Jansone, B., Poikāns, J., Bisenieks, E., Klusa, V. Z., et al. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24396 · Cited by 57 · see citing works

Impact of Sleep Disorder as a Risk Factor for Dementia in Men and Women

Jee, H. J., Shin, W., Jung, H. J., Kim, B., Lee, B. K., & Jung, Y.-S. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.192 · Cited by 57 · see citing works

Hypoxia and GABA shunt activation in the pathogenesis of Alzheimer's disease

Salminen, A., Jouhten, P., Sarajärvi, T., Haapasalo, A., & Hiltunen, M. O. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.11.005 · Cited by 54 · see citing works

The neurochemistry of agitation in Alzheimer’s disease: a systematic review

Liu, K. Y., Stringer, A., Reeves, S., & Howard, R. J. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.03.003 · Cited by 54 · see citing works

γ-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases

Łątka, K., Jończyk, J., & Bajda, M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.126 · Cited by 53 · see citing works

α-Melanocyte Stimulating Hormone Prevents GABAergic Neuronal Loss and Improves Cognitive Function in Alzheimer's Disease

Ma, K., & McLaurin, J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5075-13.2014 · Cited by 52 · see citing works

Towards screening the neurotoxicity of chemicals through feces after exposure to methylmercury or inorganic mercury in rats: A combined study using gut microbiome, metabolomics and metallomics

Lin, X., Zhao, J., Zhang, W., He, L., Wang, L., Li, H., Liu, Q., Cui, L., Gao, Y., Chen, C., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124923 · Cited by 52 · see citing works

Monoamine Oxidase Inhibitors and Neuroprotection

Al-Nuaimi, S. K., MacKenzie, E. M., & Baker, G. B. (2012) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31825b9eb5 · Cited by 51 · see citing works

Can zebrafish be used as animal model to study Alzheimer's disease?

Santana, S., Rico, E. P., & Burgos, J. S. (2012) · Europe PMC (PubMed Central) · Cited by 51 · see citing works

The role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease

Cheng, X., Wu, J., Geng, M., & Xiong, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.021 · Cited by 48 · see citing works

The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer’s Disease

Shenoy, A., Banerjee, M., Upadhya, A., Bagwe‐Parab, S., & Kaur, G. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.861155 · Cited by 47 · see citing works

Non-pharmacological treatment changes brain activity in patients with dementia

Shigihara, Y., Hoshi, H., Shinada, K., Okada, T., & Kamada, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-63881-0 · Cited by 48 · see citing works

An immunohistochemical study of GABAA receptor gamma subunits in Alzheimer's disease hippocampus: Relationship to neurofibrillary tangle progression

Iwakiri, M., Mizukami, K., Ikonomović, M. D., Ishikawa, M., Abrahamson, E. E., DeKosky, S. T., & Asada, T. (2008) · Neuropathology · doi:10.1111/j.1440-1789.2008.00978.x · Cited by 46 · see citing works

Use of Gabapentin in the Treatment of Behavioural and Psychological Symptoms of Dementia

Kim, Y., Wilkins, K. M., & Tampi, R. R. (2008) · Drugs & Aging · doi:10.2165/00002512-200825030-00002 · Cited by 45 · see citing works

Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque

Holland, J. P., Liang, S. H., Rotstein, B. H., Collier, T. L., Stephenson, N. A., Greguric, I. D., & Vasdev, N. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3158 · Cited by 43 · see citing works

Altered neurochemical profile in the M cGill‐ R ‐ T hy1‐ APP rat model of A lzheimer's disease: a longitudinal in vivo 1 H MRS study

Nilsen, L. H., Melø, T. M., Sæther, O., Witter, M. P., & Sonnewald, U. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12003 · Cited by 43 · see citing works

Very low doses of muscimol and baclofen ameliorate cognitive deficits and regulate protein expression in the brain of a rat model of streptozocin-induced Alzheimer's disease

Piļipenko, V., Narbute, K., Beitnere, U., Rumaks, J., Pupure, J., Jansone, B., & Klusa, V. Z. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.012 · Cited by 42 · see citing works

The role of polyunsaturated fatty acids in neuronal signaling in depression and cognitive processes

Stachowicz, K. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109555 · Cited by 40 · see citing works

Aromas Influencing the GABAergic System

Hartley, N., & Mclachlan, C. (2022) · Molecules · doi:10.3390/molecules27082414 · Cited by 38 · see citing works

Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids

Steffan, T., Renukappa-Gutke, T., Höfner, G. C., & Wanner, K. T. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.035 · Cited by 38 · see citing works

Neuroprotective action of proline-rich polypeptide-1 in β-amyloid induced neurodegeneration in rats

Yenkoyan, K. B., Safaryan, K., Chavushyan, V. A., Meliksetyan, I. B., Navasardyan, G., Sarkissian, J. S., Galoyan, A. A., & Aghajanov, M. I. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.08.003 · Cited by 37 · see citing works

Use of Low-Dose Gabapentin for Aggressive Behavior in Vascular and Mixed Vascular/Alzheimer Dementia

Cooney, C., Murphy, S., Tessema, H., & Freyne, A. (2013) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.12050115 · Cited by 36 · see citing works

Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1–mGAT4: Synthesis and biological evaluation

Schaffert, E. S., Höfner, G. C., & Wanner, K. T. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.08.039 · Cited by 35 · see citing works

Pharmacological Therapy for Apathy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Sepehry, A. A., Sarai, M., & Hsiung, G. R. (2017) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.426 · Cited by 35 · see citing works

Functional changes in brain oscillations in dementia: a review

Giustiniani, A., Danesin, L., Bozzetto, B., Macina, A., Benavides‐Varela, S., & Burgio, F. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0010 · Cited by 48 · see citing works

Medicinal Chemistry of ρ GABACReceptors

Ng, C. K. L., Kim, H.-L., Gavande, N. S., Yamamoto, I., Kumar, R., Mewett, K. N., Johnston, G. A. R., Hanrahan, J. R., & Chebib, M. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.10.286 · Cited by 35 · see citing works

Spatial variability and reproducibility of GABA‐edited MEGA‐LASER 3D‐MRSI in the brain at 3 T

Hnilicová, P., Považan, M., Strasser, B., Andronesi, O. C., Gajdošík, M., Dydak, U., Ukropec, J., Dobrota, D., Trattnig, S., & Bogner, W. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3613 · Cited by 32 · see citing works

Biphasic Alteration of the Inhibitory Synapse Scaffold Protein Gephyrin in Early and Late Stages of an Alzheimer Disease Model

Kiss, É., Gorgas, K., Schlicksupp, A., Groß, D., Kins, S., Kirsch, J., & Kuhse, J. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.05.013 · Cited by 34 · see citing works

Les antiépileptiques thymorégulateurs dans le traitement des symptômes comportementaux et psychologiques de la démence (SCPD)

Pinheiro, D. (2008) · L Encéphale · doi:10.1016/j.encep.2007.10.006 · Cited by 34 · see citing works

Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach—A Comprehensive Narrative Review

Uceda, S., Echeverry‐Alzate, V., Reiriz, M., Miguel, E. M., Pérez-Curiel, A., Gómez-Senent, S., & Beltrán-Velasco, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713294 · Cited by 35 · see citing works

Influence of hippocampal GABAB receptor inhibition on memory in rats with acute β-amyloid toxicity

Almasi, A., Zarei, M., Raoufi, S., Sarihi, A., Salehi, I., Komaki‬, A., Hashemi-Firouzi, N., & Shahidi, ‬. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0292-5 · Cited by 31 · see citing works

Gut as the target tissue of mercury and the extraintestinal effects

Tian, X., Lin, X., Zhao, J., Cui, L., Gao, Y., Yu, Y., Li, Y., & Li, Y. (2022) · Toxicology · doi:10.1016/j.tox.2022.153396 · Cited by 30 · see citing works

Decreased GABA levels of the anterior and posterior cingulate cortex are associated with executive dysfunction in mild cognitive impairment

Fu, X.-N., Qin, M., Liu, X., Cheng, L., Zhang, L., Zhang, X., Lei, Y., Zhou, Q., Sun, P., Lin, L., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1220122 · Cited by 29 · see citing works

Brain type carnosinase in dementia: a pilot study

Balion, C. M., Benson, C. M., Raina, P. S., Παπαϊωάννου, Α., Patterson, C., & Ismaila, A. (2007) · BMC Neurology · doi:10.1186/1471-2377-7-38 · Cited by 29 · see citing works

Psychiatric and behavioral symptoms in Alzheimer’s disease and other dementias: Etiology and management

Aarsland, D., Sharp, S. I., & Ballard, C. G. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0058-4 · Cited by 29 · see citing works

Behavioural genetics of Alzheimer's disease: a comprehensive review

Flirski, M., Sobów, T., & Kłoszewska, I. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.22068 · Cited by 28 · see citing works

Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT

Declercq, L., Vandenberghe, R. R., Laere, K. V., Verbruggen, A., & Bormans, G. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00088 · Cited by 25 · see citing works

The role of monoamines in the development of Alzheimer's disease and neuroprotective effect of a proline rich polypeptide

Yenkoyan, K. B., Fereshetyan, K., Matinyan, S., Chavushyan, V. A., & Aghajanov, M. I. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.05.013 · Cited by 25 · see citing works

Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease

Chib, S., Dutta, B. J., Chalotra, R., Abubakar, M., Kumar, P., Singh, T. G., & Singh, R. (2024) · Phytotherapy Research · doi:10.1002/ptr.8406 · Cited by 24 · see citing works

Synthesis of 4-substituted nipecotic acid derivatives and their evaluation as potential GABA uptake inhibitors

Hellenbrand, T., Höfner, G. C., Wein, T., & Wanner, K. T. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.038 · Cited by 24 · see citing works

An Overlooked Prebiotic: Beneficial Effect of Dietary Nucleotide Supplementation on Gut Microbiota and Metabolites in Senescence-Accelerated Mouse Prone-8 Mice

Ding, T., Xu, M., & Li, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.820799 · Cited by 24 · see citing works

Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer’s disease

Bories, C., Arsenault, D., Lemire, M., Tremblay, C., Koninck, Y. D., & Calon, F. (2017) · Aging · doi:10.18632/aging.101239 · Cited by 24 · see citing works

Synthesis of 3‐Azabicyclo[3.2.0]heptane Derivatives as γ‐Aminobutyric Acid Analogues through Intermolecular [2+2] Photocycloaddition

Petz, S., & Wanner, K. T. (2013) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201201723 · Cited by 23 · see citing works

New insights into clinical trial for colostrinin™ in Alzheimer's disease

Szaniszlo, P., Germán, P., Hajas, G., Saenz, D. N., Kruzel, M. L., & Boldogh, I. R. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0065-2 · Cited by 23 · see citing works

In Vivo Imaging of Neurotransmission and Brain Receptors in Dementia

Pappatà, S., Salvatore, E., & Postiglione, A. (2008) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00194.x · Cited by 23 · see citing works

Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer’s Disease

Huang, C., & Isidoro, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161238 · Cited by 23 · see citing works

The GABA–Working Memory Relationship in Alzheimer’s Disease

Mandal, P. K., Kansara, K., & Dabas, A. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170003 · Cited by 23 · see citing works

Creatine Enhances Transdifferentiation of Bone Marrow Stromal Cell-Derived Neural Stem Cell Into GABAergic Neuron-Like Cells Characterized With Differential Gene Expression

Darabi, S., Tiraihi, T., Delshad, A. A., Sadeghizadeh, M., Taheri, T., & Hassoun, H. K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9782-9 · Cited by 22 · see citing works

Special Geriatric Psychiatry Section GABAergic Function in Alzheimer’s Disease: Evidence for Dysfunction and Potential as a Therapeutic Target for the Treatment of Behavioural and Psychological Symptoms of Dementia

Lanctôt, K. L., Herrmann, N., Mazzotta, P., Khan, L. R., & Ingber, N. (2015)

Treatment Options in Alzheimer´s Disease: The GABA Story

Solas, M., Puerta, E., & Ramírez, M. J. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150914121149 · Cited by 122 · see citing works

Behavioral correlates of GABAergic disruption in Alzheimer's disease

Lanctôt, K. L., Herrmann, N., Rothenburg, L. S., & Eryavec, G. M. (2006) · International Psychogeriatrics · doi:10.1017/s1041610206003899 · Cited by 59 · see citing works

Znaczenie układu GABA w patogenezie choroby Alzheimera oraz jako potencjalnego punktu uchwytu działania nowych leków

Nowak, N., Bieńkowski, P., Kołaczkowski, M., Samochowiec, J., & Mierzejewski, P. (2014) · Postępy Psychiatrii i Neurologii · doi:10.1016/j.pin.2014.03.008

accumulating evidence indicates that changes in GABAergic neurotransmission are involved in the pathology of AD and may be an important target for pharmacological treatments.

Limón, A., Reyes‐Ruiz, J. M., & Miledi, R. (2011)